Google’s DeepMind, UK’s NHS Criticized for Sharing Data

Two reports raise concerns about privacy and proper consent during a controversial data-sharing agreement, but find that only the National Health Service broke the law.

Written byDiana Kwon
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, PHOTOBYLOVELast year, New Scientist revealed that DeepMind Health (DMH), a London-based, Google-owned artificial intelligence (AI) company, had access to the health records of 1.6 million patients, and had received them without proper consent.

This occurred through a data-sharing agreement the company made with the Royal Free NHS (National Health Service) Foundation Trust to test and develop an app called Streams, which monitors patients with kidney disease.

In a report released Monday (July 3), the Information Commissioner’s Office (ICO), an independent body in the U.K. set up to uphold information rights, found that the Trust breached the Data Protection Act when it provided Google with patients’ information. The ICO also noted that there were several issues with how data were handled, such as the lack of proper informed consent.

“Patients would not have reasonably expected their information to have been used in this way, and the Trust could and should have been far more transparent with patients as to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform